A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma-Reference-Cited by-同舟云学术

A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma

Published:2023-05 Issue: Volume:68 Page:100957
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Liang Qian,Gong Miaomiao,Zou Jing-Hua,Luo Ming-yu,Jiang Lu-lu,Wang Cheng,Shen Ning-xiang,Zhang Mo-cong,Xu Lu,Lei Hui-min,Zhang Ke-Ren,Zhang Rui,Zhuang Guanglei,Zhu Liang,Chen Hong-zhuan,Zhou Lu,Shen Ying^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference48 articles.

1. A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo;Bai;Cancer Cell,2019

2. CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity;Chen;Cell Death Differ.,2020

3. Selectively targeting STAT3 using a small molecule inhibitor is a potential therapeutic strategy for pancreatic cancer;Chen;Clin. Cancer Res.,2023

4. IL6 promotes a STAT3-PRL3 feedforward loop via SHP2 repression in multiple myeloma;Chong;Cancer Res.,2019

5. STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis;Dawson;Gut,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression;Acta Pharmaceutica Sinica B;2024-09

2. GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma;Oncogene;2024-07-05

3. Tanshinone IIA acts as a regulator of lipogenesis to overcome osimertinib acquired resistance in lung cancer;Biochemical Pharmacology;2024-06

4. Enhancement of Chemotherapy Efficacy in Cervical Cancer via MAPK Pathway Inhibition by Osimertinib;Cancer Investigation;2024-05-27

5. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer;Frontiers in Oncology;2024-04-18